Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00800371|
Recruitment Status : Unknown
Verified November 2008 by University Hospital Tuebingen.
Recruitment status was: Recruiting
First Posted : December 2, 2008
Last Update Posted : December 2, 2008
Juvenile idiopathic arthritis (JIA) may progress asymptomatically leading to joint destruction despite treatment.
The aim of the observational study is to describe patients with silent arthritis comparing symptoms, clinical findings with results of ultrasound and magnetic resonance imaging (MRI).
|Condition or disease||Intervention/treatment|
|Juvenile Idiopathic Arthritis||Procedure: intra-articular steroid injection|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Diagnostic Value of MRI and Ultrasound in Patients With JIA|
|Study Start Date :||May 2008|
|Estimated Primary Completion Date :||December 2009|
|Estimated Study Completion Date :||June 2010|
Patients with JIA
Procedure: intra-articular steroid injection
Steroid injection into otherwise noncontrollable arthritis.
- Definition of patients with silent arthritis. [ Time Frame: every three to six months from recruitment to end of study ]
- Comparison of diagnostic value of MRI and ultrasound. [ Time Frame: every three to six months from recruitment to end of study ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00800371
|Contact: Nikolay Tzaribachev, MD||+49707129 ext firstname.lastname@example.org|
|University Children's Hospital||Recruiting|
|Tuebingen, Baden-Wuerttemberg, Germany, 72076|
|Principal Investigator: Nikolay Tzaribachev, MD|
|Principal Investigator:||Nikolay Tzaribachev, MD||University Hospital Tuebingen|